Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 422-940-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October 31, 1995 to January 18, 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to OECD test guideline No. 414 and in compliance with GLP, without major deviation.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Version / remarks:
- (1981)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 422-940-4
- EC Name:
- -
- Cas Number:
- 155633-54-8
- Molecular formula:
- C24H39N3O3Si3
- IUPAC Name:
- 2-(2H-1,2,3-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-(2,2,4,6,6-pentamethyl-3,5-dioxa-2,4,6-trisilaheptan-4-yl)propyl]phenol
- Test material form:
- other: Solid
- Details on test material:
- - Name of test material (as cited in study report): G4375
- Physical state: whitish solid (powder)
- Analytical purity: 98% minimum
- Impurities (identity and concentrations): Methanol (<100 ppm) and Isopropanol (<100 ppm)
- Purity test date: certificate of analysis 20/10/1995
- Lot/batch No.: DEF/C 95003/B
- Expiration date of the lot/batch: No data
- Stability under test conditions: in the vehicle (bi-distilled water with 4% Methylcellulose and 1% Tween 80): stable at least 4 hours
- Storage condition of test material: at room temperature (approx.20°C) protected from light.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratories, Ltd. Wölferstrasse 4, 4414 Füllinsdorf / Switzerland
- Age at study initiation:
Dose-range finding test: 10 weeks old at pairing
Main test: 11 weeks minimum
- Weight at study initiation:
Dose-range finding test: 212 - 269 grams at Day 0 post coitum.
Main test: 207-294 grams at Day 0 post coitum
- Fasting period before study: no
- Housing:
The rats were housed individually in Makroton cages (type-3) with wire mesh tops and standardized granulated softwood bedding (Lignocel, Schill AG, CH-4132 Muttenz / Switzertand).
- Diet (e.g. ad libitum): Pelleted standard Kliba 343 rat/mouse maintenance diet ("Kliba", Klingentalava- muehle AG, CH 4303 Kaiseraugst / Switzerland) was available ad libitum (Batch no. 69/95 and 71/95).
- Water (e.g. ad libitum): Tap water in bottles was available ad libitum. Results of bacteriological, chemical and contaminant analyses scheduled to be conducted at Ieast once yearly by RCC (contaminant analyses only) and by the Official Chemist of the Kanton Basel-Landschaft (bacteriological and chemical analyses).
- Acclimation period: 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-3°C
- Humidity (%): 40-70 %
- Air changes (per hr): 10 to 15
- Photoperiod (hrs dark / hrs light): 12h dark/ 12h light
IN-LIFE DATES (main study): From 08 December 1995 to 18 January 1996
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Bi-distilled water with 4% Methylcellulose and 1% Tween 80
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The mixtures of the test article and vehicle were prepared daily before administration. The test article was weighed into a glass beaker on a tared precision balance (Mettler PE 360) and the vehicle added (w/w). The mixtures were prepared using a mortar and pestle and a magnetic stirrer. During the daily administration period, homogeneity was maintained using a magnetic stirrer.
VEHICLE
- Amount of vehicle (if gavage): 10 ml/kg body weight, with a daily adjustment of the individual volume to the actual body weight. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Homogeneity and stability of the test article/vehicle mixtures were determined during the dose range-finding study. Samples were taken immediately after preparation and again 4 hours later. During the dosing period of this study, additional sample for confirmation of the concentration, homogeneity and stability were taken at the initiation and the termination of the dosing period (mean deviation from nominal concentration: 15% maximum). Analyses were performed by the RCC Analytical Chemistry Laboratory using a method developed by RCC. The concentration of the test material in formulations was determined by High-performance liquid chromatography (HPLC).
CONCENTRATIONS:
The mean concentrations of the homogeneity samples were found to be 97.5%, 99.5% and 100.1% of the nominal concentrations of 10 mg/ml, 30 mg/ml and 100 mg/ml, respectively.
HOMOGENEITY:
The homogeneity varied in the range from -3% to +2% of the mean concentrations.
STABILITY:
The test item was found to be stable in the vehicle at room temperature for at least four hours - Details on mating procedure:
- - Impregnation procedure: cohoused
- M/F ratio per cage: 1 male ; 1 female
- Length of cohabitation: overnight
- The males used for mating were delivered on the same date as the females. Therefore the fertility could not be proofed previously.
- Further matings after two unsuccessful attempts: no
- Verification of same strain and source of both sexes: no data
- Proof of pregnancy: vaginal plug or sperm in vaginal smear referred to as day 0 post coitum (pregnancy) - Duration of treatment / exposure:
- From Day 6 to 15 post coitum.
- Frequency of treatment:
- Daily
- Duration of test:
- 15 Days
- No. of animals per sex per dose:
- Range-finding study: 6 females/dose
Main test: 25 females/dose - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: determined in RCC study 365534
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: The animals were checked at least twice daily for any mortalities.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: The animals were observed at least twice daily for signs of reaction to treatment and/or symptoms of ill health,
BODY WEIGHT: Yes
- Time schedule for examinations: Body weights were recorded daily, from day 0 until day 21 post coitum.
FOOD CONSUMPTION : Yes
Food consumptions were recorded for the following periods: days 0-6, 6-11, 11-16 and 16-21 post coitum
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21
- Organs examined: all internal organs, with emphasis on the uterus, uterine contents, position of fetuses in the uterus and number of corpora lutea
When considered appropriate, macroscopic changes in the dams were photographed and samples of tissue fixed in neutral phosphate buffered 4% formaldehyde solution for possible microscopic examination. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
For the reproduction data, group mean values were calculated both on a per dam basis and on a percentage per group basis. Only dams with live fetuses on day 21 post coitum were included in the calculations. - Fetal examinations:
- - External examinations: Yes: all per litter
- Soft tissue examinations (viscera and brain): Yes: half per litter
- Skeletal examinations: Yes: half per litter
- Head examinations: No - Statistics:
- The following statistical methods were used to analyze body weights, food consumption and reproduction and skeletal examination data:
- Univariate one-way analysis of variance was used to assess the significance of intergroup differences if the variables could be assumed to follow a normal distribution
- The Dunnett-test (many-one t-test), based on a pooled variance estimate, was applied for the comparison between the treated groups and the control group.
- The Steel test (many-one rank test) was applied when the data could not be assumed to follow a normal distribution.
- Fisher's Exact test for 2x2 tables was applied if the variables could be dichotomized without loss of information.
Individual values, means, standard deviations and t-statistics were rounded off before printing. - Indices:
- Percentage pre-implantation loss was calculated as:
(Number of corpora lutea - Number of implantations)/ Number of corpora lutea x 100
Percentage post-implantation loss was calculated as:
(Number of implantations - Number of live foetuses)/ Number of implantations x 100
Sex ratio of males/females (%) was calculated as:
(number of males/females)/ number of implantations x 100 - Historical control data:
- Historical control were provided in the study (Reproduction data of dams, spontaneous abnormal findings of fetuses (external, visceral or skeletal examination), skeletal examination of fetuses (stage of development) on fetus basis or on litter basis, Necropsy findings)
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
There were no deaths during the course of this study, no clinical signs or symptoms were observed and no abnormal findings were attributed to treatment with the test item. Treatment with the test article caused slightly reduced food consumption during the dosing period in the dams at 1000 mg/kg bw/day, with statistical significance during days 6-11 post coitum (Dunnett-test, p<0.05). This finding was considered to be incidental; no effects were noted upon the mean body weights.
The differences amongst the reproduction parameters of the dams dosed with the test item and the vehicle control group gave no indication of test article related effects. The small differences noted were within the normal the normal range of deviations for animals of this strain and age and were considered to be incidental.
No indications of test article related macroscopic changes were noted during necropsy. Common abnormal macroscopic findings were noted in four females of the groups treated with 0, 100 and 1000 mg/kg bw/day, respectively and in one female of group treated with 300 mg/kg bw/day.
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
The foetal parameters - external examination, visceral or skeletal examinations, sex ratios and body weights - yielded no reference to test article related effects.
In the fetuses of the group at 300 mg/lk bw/day, one had a rudimentary tail and in another the left fore paw was caudaly flexed. In the group at 1000 mg/kg bw/day one fetus had the left hindleg caudally malpositioned. Those findings were considered to be spontaneous changes commonly noted in fetuses of this rat strain.
The marginally increased mean body weights in group at 300 mg/kg bw/day was considered to be an effect of the different number of fetuses per dams (15.6 in vehicle control group Vs 14.8 in group treated at 300 mg/kg bw/day).
No abnormalities were noted during visceral examination.
The common abnormal findings noted were within the normal range of variation for fetuses of this rat strain and therefore considered to be incidental.
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Sex:
- male/female
- Basis for effect level:
- other:
- Remarks on result:
- other: No significant effects upon offspring viability, growth or development.
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Conclusions:
- The oral administration of the test material at dose levels up to 1000 mg/kg bw/d, to pregnant rats from Day 6 to Day 15 of gestation resulted in no significant systemic effects on the adults. There were no significant effects on any of the uterine parameters examined. There were no significant effects upon offspring viability, growth or development. The No Observed Adverse Effect Level (NOAEL) for adult toxicity and developmental toxicity was 1000 mg /kg bw/d.
- Executive summary:
In a developmental toxicity study conducted according to the OECD guideline No. 414 and in compliance with GLP, the test material diluted in bi-distilled water with 4% Methylcellulose and 1% Tween 80 was administered to 25 mated females Sprague-Dawley rats/dose by gavage at dose levels of 0, 100, 300 and 1000 mg/kg bw from day 6 post coitum through day 15 post coitum. The dosages were based on a range-finding study. Individual clinical observations, bodyweight and food consumption were recorded during the study. The females were sacrificed on Day 21 of gestation, examined macroscopically and the uterine contents examined. The number of corpora lutea, implantation number, foetal and placental weights, foetal sex, and external appearance were recorded. All live foetuses were preserved, processed and subsequently examined for skeletal or visceral anomalies.
There were no deaths during the course of this study, no clinical signs or symptoms were observed and no abnormal findings were attributed to treatment with the test item. Treatment with the test article caused slightly reduced food consumption during the dosing period in the dams at 1000 mg/kg bw/day, with statistical significance during days 6-11 post coitum (Dunnett-test, p<0.05). This finding was considered to be incidental; no effects were noted upon the mean body weights.
The differences amongst the reproduction parameters of the dams dosed with the test item and the vehicle control group gave no indication of test article related effects. The small differences noted were within the normal the normal range of deviations for animals of this strain and age and were considered to be incidental.
The foetal parameters - external examination, visceral or skeletal examinations, sex ratios and body weights - yielded no reference to test article related effects.
The oral administration of the test material at dose levels up to 1000 mg/kg bw/day, to pregnant rats from Day 6 to 15 of gestation resulted in no significant systemic effects on the adults. There were no significant effects on any of the uterine parameters examined. There were no significant effects upon offspring viability, growth or development.
The No Observed Adverse Effect Level (NOAEL) for adult toxicity and developmental toxicity was 1000 mg /kg bw/day.
Under the test conditions, the test material is not classified according to the annex VI of the Regulation (EC) No. 1272/2008 (CLP).
This study is acceptable and satisfies the requirement for developmental toxicity endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.